A carregar...
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
BACKGROUND: Currently, the most frequently used secondary treatment for patients with venous thromboembolism (VTE) consists of vitamin K antagonists (VKA) targeted at an international normalized ratio (INR) of 2.5 (range 2.0 to 3.0). However, based on the continuing risk of bleeding and uncertainty...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2014
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7074008/ https://ncbi.nlm.nih.gov/pubmed/25092359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001367.pub3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|